Market Tracker

06/23 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.915
Delayed Data
As of Jun 23
 -0.075 / -7.58%
Today’s Change
0.86
Today|||52-Week Range
5.74
-59.33%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.99
Today’s open0.99
Day’s range0.90 - 1.04
Volume4,554,369
Average volume (3 months)1,003,465
Market cap$48.7M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+20.97%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
ITEKInotek Pharmaceutica...-0.10-5.26%
SCYXSCYNEXIS Inc-0.01-0.52%
CTRVContraVir Pharmaceut...-0.00-0.63%
BLPHBellerophon Therapeu...+0.08+5.84%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts